Mangoceuticals, Inc. (MGRX) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.40. It has a SharesGrow Score of 35/100, indicating a weak investment profile with 0 out of 7 criteria passed.
Valuation: MGRX trades at a trailing Price-to-Earnings (P/E) of -0.2 (S&P 500 average ~25).
Financials: revenue is $304,808, +2672.3%/yr average growth. Net income is $21M (loss), growing at -164.2%/yr. Net profit margin is -6772.6% (negative). Gross margin is 82.1% (+27.8 pp trend).
Balance sheet: total debt is $307,823 against $15M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 1.74 (strong liquidity). Debt-to-assets is 1.9%. Total assets: $16M.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).
